Highlights Seegene, Inc.

Equities

A096530

KR7096530001

End-of-day quote Korea S.E. Other stock markets 23:00:00 08/05/2024 BST			5-day change	1st Jan Change
22,250 ^KRW	-0.45%		+0.45%	-2.84%

03-14	Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-24	Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	01-24	CI
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing	12-14	MT
Microbix Brief: Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy	12-14	MT
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on July 13, 2023.	13/10/23	CI
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.	28/08/23	CI
Seegene, Inc.'s Equity Buyback announced on February 28, 2023, has expired with 2,046,354 shares, representing 4.11% for KRW 49,998.4 million.	27/08/23	CI
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC	31/07/23	CI
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.	13/07/23	CI
Seegene, Inc. authorizes a Buyback Plan.	12/07/23	CI
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays	14/06/23	CI
Seegene and Werfen Partner to Collaborate on OneSystem(TM) Business to Develop Syndromic qPCR Assays	14/06/23	CI
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.	30/05/23	CI
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on September 28, 2022.	28/03/23	CI
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on September 28, 2022.	28/03/23	CI
Seegene, Inc.'s Equity Buyback announced on September 28, 2022, has expired with 1,780,608 shares, representing 3.56% for KRW 49,330.84 million.	27/03/23	CI
Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.	28/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Seegene, Inc.

Equities

A096530

KR7096530001

Highlights

Filters